Congressional trade$1,001 - $15,000Reported range · official band, not an exact amount
2 different filers disclosed AMGN within 90 days. Disclosed 10 days after the transaction; reported as an official range, not an exact amount.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$825K of AMGN shares in the open market
Traded Aug 11, 2026 · Filed Aug 13, 2026
- ~$825K
- Reported value · 2,000 sh @ $412.567
- 6,404
- Holds after · shares reported
- -2.7%
- stock since the trade · S&P 500 +0.6%, $414.30 → $402.98 on Oct 5
Why it stands out
Amgen's SVP, Business Development sold $825K of Amgen shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 11, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 13, 2026
Officer$500K–$1M
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$825,134
Shares × reported transaction price
- Timing vs results
7 days after results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Price at the time
Closed at $414.30 on Aug 11, 2026, within 1% of its 52-week high, after a 15% rise over the previous 30 trading days
Congressional trade